Literature DB >> 21421890

Tissue factor and tissue factor pathway inhibitors TFPI and TFPI2 in human secretory endometrium--possible link to female infertility.

Signe Altmäe1, Andres Salumets, Kerstin Bjuresten, Theodora Kunovac Kallak, Kjell Wånggren, Britt-Marie Landgren, Outi Hovatta, Anneli Stavreus-Evers.   

Abstract

The aim of this study was to investigate tissue factor (TF) and its inhibitors TFPI and TFPI2 in secretory endometrium of fertile women and in women with unexplained infertility in relation to endometrial receptivity. In addition, common variation in the regulatory area of TF and TFPI genes was studied. Immunostaining of TF and TFPI, together with the appearance of pinopodes, revealed similar expression pattern in fertile endometrium throughout the secretory phase, being highest at the time of implantation. When compared protein expression levels at the time of implantation, infertile women demonstrated significantly higher TFPI expression in luminal epithelium. Furthermore, polymorphism TF -603 A/G was associated with the endometrial protein level in infertile women, being highest in women with GG genotype, and variation TFPI -287 T/C was associated with unexplained infertility, where infertile women presented more frequently T allele than fertile women. Contrary to TF and TFPI, TFPI2 showed different mRNA and protein expression patterns in fertile endometrium, and no differences between fertile and infertile women were detected. We conclude that the TF pathway is involved in normal endometrial maturation, where TF and TFPI seem to have important roles at the time of embryo implantation. Higher TFPI expression level during the time of embryo implantation and TFPI -287 T allele could be risk factors for unexplained infertility. No distinct involvement of TFPI2 in the regulation of endometrial receptivity and unexplained infertility was found.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21421890     DOI: 10.1177/1933719111400633

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  6 in total

1.  Research resource: interactome of human embryo implantation: identification of gene expression pathways, regulation, and integrated regulatory networks.

Authors:  Signe Altmäe; Jüri Reimand; Outi Hovatta; Pu Zhang; Juha Kere; Triin Laisk; Merli Saare; Maire Peters; Jaak Vilo; Anneli Stavreus-Evers; Andres Salumets
Journal:  Mol Endocrinol       Date:  2011-11-10

2.  No evidence for mutations in NLRP7, NLRP2 or KHDC3L in women with unexplained recurrent pregnancy loss or infertility.

Authors:  L Aghajanova; S Mahadevan; S Altmäe; A Stavreus-Evers; L Regan; N Sebire; P Dixon; R A Fisher; I B Van den Veyver
Journal:  Hum Reprod       Date:  2014-11-05       Impact factor: 6.918

Review 3.  Review on autoimmune reactions in female infertility: antibodies to follicle stimulating hormone.

Authors:  Kadri Haller-Kikkatalo; Andres Salumets; Raivo Uibo
Journal:  Clin Dev Immunol       Date:  2011-10-05

4.  Deep sequencing of transcriptome profiling of GSTM2 knock-down in swine testis cells.

Authors:  Yuqi Lv; Yi Jin; Yongqiang Zhou; Jianjun Jin; Zhenfa Ma; Zhuqing Ren
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

5.  Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study.

Authors:  Grigoris T Gerotziafas; Patrick Van Dreden; Emmanuelle Mathieu d'Argent; Eleftheria Lefkou; Matthieu Grusse; Marjorie Comtet; Rabiatou Sangare; Hela Ketatni; Annette K Larsen; Ismail Elalamy
Journal:  Thromb J       Date:  2017-03-28

6.  Tissue factor pathway inhibitor‑2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix.

Authors:  Yukihide Ota; Shiro Koizume; Yoshiyasu Nakamura; Mitsuyo Yoshihara; Tomoko Takahashi; Shinya Sato; Shohei Myoba; Norihisa Ohtake; Hisamori Kato; Tomoyuki Yokose; Etsuko Miyagi; Yohei Miyagi
Journal:  Oncol Rep       Date:  2021-01-20       Impact factor: 3.906

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.